The International Registry for Alzheimer’s Disease and Other Dementias Foundation (InRAD) would like to thank and acknowledge the following organisations for their early financial contributions:
‍

Eli Lilly and Company Ltd

For their collaborative research agreement to support the data entry portal and registry platform build, medical writing and project management services for Alzheimers Europe 2024, CTAD 2024 and ADPD 2025
‍

Novo Nordisk

For their grant to support medical writing, design and project management services at AAIC 2024

‍
‍

Bristol Myers Squibb

For their contribution toward supporting the registry platform build.
‍
‍

Other Partnerships:
‍

Alzheimer's Network

InRAD is pleased to announce a collaboration with Alzheimers Network (Alz Net). ALZ-NET is a voluntary health care provider-enrolled patient network and we aim to collaborate to advance goals to improve patient care. Learn more about Alz Net HERE